Rating: Neutral | Target price range: RMB 6.8–7.6 (fair under the base scenario, midpoint ~RMB 7.2) | Current price: RMB 7.18 (close on 2026-10-26, the valuation anchor frozen for this report) | Total market cap: ~RMB 71.2 billion | Time horizon: 6–12 months | Margin of safety: ~ -5% (base-case fair value floor of RMB 6.8 vs. current price)
Changan Automobile is at the intersection of three overlapping phases: "domestic share loss + earnings bottoming + overseas succession." From January to September 2026, sales were 1,692,700 units (-18.07%), significantly underperforming a broadly flat industry. In 2026H1, net profit attributable to shareholders was RMB 817 million (-64.32%), with non-recurring-adjusted profit of only RMB 251 million (-83.01%), implying about RMB 224 per vehicle. At the current price of RMB 7.18, the PB of 0.94x (5th percentile over the past 5 years, near the 5-year low) almost coincides with the zero-growth economic profit value (EPV ~RMB 7.22/share) — the market is essentially paying only for "the status quo plus net cash of ~RMB 38.6 billion," without paying for options such as overseas volume growth, Deepal's loss reduction, or Avatr's IPO. Yet the 2027 recovery expectations (sell-side consensus of ~RMB 5.9 billion attributable profit) are also not embedded as much redundancy in the current price. This report judges the valuation as fair: there is neither evidence of undervaluation nor of overvaluation; rating is Neutral — the probability-weighted expected value across three scenarios is ~RMB 7.29, only +1.5% above the current price; downside to the bear case of -13.6%~-26.2% and upside to the bull case of +29.5%~+43.5% are roughly symmetric but offer no margin of safety. The inflection verification points are dense and imminent: the Q3 earnings report on October 31, whether Q4 monthly sales declines can narrow, the completion of the RMB 5.267 billion private placement (RMB 9.41/share, with the major shareholder subscribing at a 31% premium), and the completion of share buyback and cancellation. Until there is substantive evidence of stabilization in the adjusted profit margin, the current price does not constitute an actionable window with a margin of safety.
Opportunity in one sentence: The current price largely prices in the midpoint between the optimistic scenario of "successful recovery in 2027" and the pessimistic scenario of "failed recovery." This is a "catalyst + inflection point verification" type of conditional opportunity — only when the Q3 report shows sequential stabilization in adjusted profit, Q4 monthly sales declines narrow to single digits, and both the private placement and buyback cancellation are realized, do the odds tilt favorably; otherwise, share loss could at any time shift the pricing framework to that of a "loss-making automaker."
The share loss cannot be explained by the industry downturn alone: the industry was broadly flat while Changan fell double digits, with own-brand declining even more sharply. But two buffering factors should be noted objectively: September single-month NEV sales of 119,800 units (+15.64%), a 55.6% share, show improving NEV mix; the production decline (-29.3%) exceeding the sales decline indicates proactive destocking. A full-year negative adjusted profit is not a foregone conclusion — H2 2025 adjusted profit was ~RMB +1.32 billion; if H2 returns to slight profit, the full-year adjusted figure could stay positive at a low level. But as long as Q4 monthly sales declines remain below -15%, the risk of turning negative is real (the 2026H1 adjusted base of only RMB 251 million is too thin). Falsification conditions: monthly sales YoY declines narrowing to single digits from October to December and a clear sequential rebound in Q3 adjusted profit.
A balanced note: the OCF deterioration contains industry-wide policy drivers — the company explained for two consecutive years as "shortening supplier payment terms" (compliance cost of the new payment-term policy for central SOEs), and the near-zero 2026H1 attributable base renders ratio denominators ineffective; the non-recurring share series is also non-monotonic (31.4% in 2025 was actually the best of the four years). But the unexplained jump in R&D capitalization ratio and the structure of "attributable profit far exceeding consolidated net profit" are hard flaws in reporting quality that require no excuse: any "profit recovery" signal must be re-verified after stripping out these three items.
Overseas is currently the only segment improving both revenue growth and gross margin structure simultaneously. But two un-digested factors must be deducted in valuation: first, the 4-percentage-point rebate cut, estimated on ex-VAT export unit prices, reduces profit by ~RMB 1,700 per vehicle; if NEV exports reach ~600,000 units in 2027, the theoretical erosion is ~RMB 1 billion (~2 percentage points of overseas net margin), unless localized capacity (Thailand/Brazil/Europe) ramps up in time or prices are raised to pass through; second, the +78.77% in 2026H1 contains an export-surge pulse ahead of the rebate cut, with risk of payback in 2027H2, and the company does not disclose overseas segment net profit — the "2027 overseas net margin of 5-6%" is this report's own assumption with no official anchor. Falsification conditions: overseas monthly sales below 80,000 units for two consecutive months, or overseas gross margin falling below 18%.
The accurate statement of the pricing logic: the current price implies operating value of ~RMB 33 billion; backing out with a 10-12% cost of equity, the market is pricing Changan's normalized attributable profit at only ~RMB 3.3-4.0 billion — below the sell-side 2027E consensus of RMB 5.95 billion (revised down 21.6% over the past 90 days) and below the annualized RMB 4.5-5.1 billion implied by management's statement "attributable profit +12% YoY excluding FX effects." In other words, the market deeply doubts the sell-side recovery narrative and pays for almost no growth options, but has fully priced in the net cash and asset base. In this landscape, there is neither evidence of "market mispricing" nor of a bubble. EPV is sensitive to maintenance capex and working capital assumptions (~±RMB 1.7/share), the largest framework risk of this judgment. Falsification conditions: stock price falling below RMB 5.3 (bear case floor) or rising above RMB 9.3 (lower bound of bull range) requires re-examination of the valuation framework.
The major shareholder's 31% premium subscription, 40% payout ratio, ongoing buyback cancellation, zero pledge, and no unlocks constitute a capital-operation support combination rare in A-shares. But four loosening points must be recorded: ① Placement approval ≠ execution — the current price is inverted 23.7% vs. the issue price; the company only states "execution at an opportune time within the approval validity period"; if the approval expires in 2027-08 without issuance, the buffer falls away; ② In 8 months, buyback has executed only ~RMB 930-960 million, near the RMB 1.0 billion lower bound, while full execution of the placement would dilute ~5.6%, netting ~+3.6% dilution against the buyback's 2% cancellation; ③ The asset support is leaking: cash decreased by ~RMB 14.37 billion in half a year (54.022→39.652 billion), and the company received entrusted loans from the group totaling RMB 1.55 billion in 2026 (at LPR-81bp), indicating that the consolidated large net cash includes financial subsidiaries and restricted funds, and operations already need shareholder liquidity support; ④ The support's executing主体 just changed (chairman transition on 2026-10-16). Until the trajectory of ROE falling from 16.8% (2023) to 5.3% (2025) reverses, PB repair lacks earnings support. Falsification conditions: placement approval expires unexecuted and buyback stops at the lower bound, or the payout ratio is significantly cut.
| Metric | FY2023 | FY2024 | FY2025 | 2026Q1 | 2026H1 (latest) |
|---|---|---|---|---|---|
| Revenue (RMB 100mn) | 1,512.98 | 1,597.33 | 1,640.00 | 327.06 | 656.34 |
| Revenue YoY | — | +5.58% | +2.67% | -4.26% | -9.71% |
| Net profit attributable (RMB 100mn) | 113.27 | 73.21 | 40.75 | 3.51 | 8.17 |
| Attributable profit YoY | — | -35.37% | -44.34% | -74.09% | -64.32% |
| Adjusted net profit (RMB 100mn) | 37.82 | 25.87 | 27.95 | 2.42 | 2.51 |
| Gross margin (%) | 17.26 | 14.94 | 15.54 | 14.08 (est.) | 14.50 |
| Attributable net margin (%) | 7.49 | 4.58 | 2.48 | 1.07 | 1.25 |
| Operating cash flow (RMB 100mn) | 198.61 | 48.49 | 18.36 (est.) | -116.47 | -114.13 |
| Free cash flow (RMB 100mn, est.) | +170.4 | ≈0 | -28.43 | -126.02 | -135.07 |
| Cash and equivalents (RMB 100mn, period-end) | — | — | 540.22 | 398.31 | 396.52 |
| Interest-bearing debt (RMB 100mn, period-end) | — | — | 25.10 | 19.73 | 19.93 |
| Debt-to-asset ratio (%) | 60.73 | 62.01 | 59.61 | 57.15 | 57.54 |
| R&D investment (RMB 100mn) | — | 101.59 | 125.76 | — | — |
Note: The 2026 Q3 report had not been disclosed as of this report's date (2026-10-27) (scheduled for 10-31); the latest periodic report is the 2026 semi-annual report; balance-sheet stock metrics are all as of 2026-06-30. Interest-bearing debt includes short-term borrowings, long-term borrowings, bonds payable, lease liabilities, and non-current liabilities due within one year (aggregate definition).
Reasons for metric changes (company's official explanations for items with YoY ≥±20%): FY2025 attributable profit -44.34%: mainly due to the high 2024 non-recurring gain base (Lingyao Plant 1 government acquisition of RMB 2.550 billion) and investment income turning negative (-RMB 430 million); adjusted profit actually +8.03%; FY2025 selling expenses +32.56% (RMB 9.993 billion): the company attributes this to increased NEV sales, new model launches and promotion, and brand advertising; FY2025 financial expenses -157% (-RMB 2.402 billion): mainly FX gains, reversing in 2026 (H1 financial expenses +103.53%): FX losses and reduced interest income; FY2025 operating cash flow -62.15%: the company explains as shortening supplier payment terms per national policy; 2026Q1 operating cash flow -232.71%: decrease in collections due YoY (company cites seasonality; Q2 turned positive); FY2025 inventory +31.87% (RMB 22.518 billion, inventory volume +56.32%): increased overseas inventory and product mix adjustment; 2026Q1 accounts receivable +179.61%: increased dealer support amid intense competition, falling back to RMB 7.50 billion by end-H1; 2026H1 financing cash flow -462%: share buyback outlays; 2026H1 asset impairment provisions of RMB 463 million (mainly inventory write-downs) reduced attributable profit by RMB 415 million.
2026H1 revenue of RMB 65.634 billion (-9.71%), attributable profit RMB 817 million (-64.32%), adjusted profit RMB 251 million (-83.01%) — the weakest half-year report in four years. The two major items behind the attributable profit collapse are declining sales and FX reversal: H1 FX losses of RMB 230 million vs. gains of RMB 1.356 billion a year earlier, a swing of ~RMB 1.59 billion in profit; management states "attributable net profit +12% YoY excluding FX effects" — implying ex-FX attributable profit of ~RMB 2.57 billion, ~RMB 2,297 per vehicle (this report's estimate), suggesting core operating profitability is not as weak as reported. But "ex-FX" is management's own framing; FX is a real P&L item, not noise, for a company with 33.4% overseas revenue share. Structural highlights are concentrated overseas: overseas revenue of RMB 21.942 billion (+78.77%) kept consolidated gross margin stable at 14.50% (-0.08pp), while domestic gross margin of 11.67% (-1.36pp) continues to decline. Negative signals are equally clear: minority interest losses of -RMB 637 million propped up nearly 80% of attributable profit; operating cash flow of -RMB 11.413 billion (Q1 -11.647 billion, Q2 turned positive — the seasonality explanation partially holds); inventory hit a record RMB 23.115 billion with RMB 468 million in write-downs. Against sell-side consensus (Q3 revenue ~RMB 34.5 billion), the H2 delivery bar is high: the sell-side full-year attributable profit of RMB 3.965 billion implies H2 of ~RMB 3.15 billion (+77% YoY), which this report views with reservation (own FY2026E attributable profit of RMB 1.8-2.6 billion).
Business model snapshot: Asset-heavy vehicle manufacturing (design capacity 2.25 million units, 2025 utilization rate 88.2%) + hybrid structure with equity-method JVs — self-owned brands (Nevo/Deepal/Avatr/Changan brand/Kaicheng) are consolidated for manufacturing and sales; Deepal (51% stake) is consolidated; Changan Ford/Changan Mazda are accounted for under the equity method; Avatr is an associate (largest shareholder, not consolidated). Revenue comes almost entirely from vehicle sales, with no subscription/recurring income; the closest thing to recurring profit comes from after-sales parts (Changan Customer Service Company's 2025 net profit of RMB 1.152 billion). Weak pricing power: ASP fell from RMB 59,500 in 2024 to RMB 56,300 in 2025; price increases can only come from exports and NEV mix upgrades.
Cash-content test of earnings: OCF/attributable net profit for 2023–2025 was 1.75→0.66→0.45 (FY2025 is an estimated figure); 2026H1 turned deeply negative — below the 0.8 warning line for two consecutive years, with the bulk of book profits not converting into cash (new payment-terms policy + lengthening export receivables); FCF was positive only in 2023 (+RMB 17.0 billion), about -RMB 2.8 billion in 2025 (estimated), and -RMB 13.507 billion in 2026H1. Recurring-earnings test: the gap between ex-non-recurring and attributable profit has been ≥15% for four consecutive years (non-recurring items accounted for 66.6%/64.7%/31.4%/69.3% of attributable profit), with a different one-off item each year from 2023–2026H1 (consolidation gains → government land buyback → government subsidies → consolidation gains) dressing up attributable profit — core earnings (ex-non-recurring) had a 2023–2025 midpoint of only about RMB 3.0 billion, and even that includes an accounting boost from the jump in R&D capitalization. Management's self-defined "excluding FX" metric must also be used with caution (see previous section).
Return on capital: ROIC of about 3.7% (2025 estimate), significantly below a WACC of around 9% — every incremental yuan of investment is currently destroying value; "scale growth" has not yet created excess returns financially; ROE trajectory: 16.8% (2023) → 9.9% (2024) → 5.3% (2025).
Capex quality: Physical CapEx/depreciation & amortization of only 0.76–0.85, with traditional capacity investment contracting; resources are shifting toward R&D (RMB 12.576 billion in 2025, RMB 5.418 billion capitalized) and equity investments (RMB 10 billion planned for 2026). The company does not disclose a split between maintenance and growth CapEx, so the true level of maintenance investment cannot be determined — this is the largest measurement risk in the EPV calculation. Red flags: heavy reliance of attributable profit on one-off gains, minority shareholders absorbing losses to prop up attributable profit, and an unexplained jump in R&D capitalization (see E4 for details); customer concentration is low (top five customers at 10.28%), so no concern there, but related-party purchases at 17.29% of total purchases warrant attention.
Consistency between words and deeds: delivered in the prior two years; 2026 targets likely to miss. 2024 target of 2.65 million units produced and sold → actual 2.684 million (delivered); 2025 target of 2.80 million → actual 2.913 million (delivered); the 2026 annual report disclosed no quantitative target, with an overseas target of 750,000 units; total sales for Jan–Sep fell -18.07%, and management acknowledged in IR activities that first-half target completion was below 50% — the 2026 target will most likely be missed. Long-term targets (total sales of 5 million/overseas 1.5 million by 2030, mass production of humanoid robots by 2028, commercial flying cars by 2030) are aggressive with no delivery track record yet; the timeline for solid-state battery vehicle validation has been made vague under investor questioning.
Shareholder-friendliness: formally friendly, substantively neutral-to-positive. Payout ratio of 30% (2023) → 40% (2024) → 40% (2025), with a dividend yield of about 2.31% at current prices; A+B share buyback-and-cancellation of RMB 1.0–2.0 billion is progressing (197 million shares as of end-September); the major shareholder subscribed to the private placement at a price 31% above market. Offsetting item: private placement dilutes 5.6% vs. buyback cancellation of 2%, for net dilution of about +3.6%.
Risk signals: ① Chairman change on 2026-10-16 (Zhu Huarong resigned as listed-company chairman but remains group chairman; Zhao Fei succeeded him and Ye Pei became president), with the board secretary position vacant and duties assumed by the chairman — only one month from the transition to the resignation, a governance transition period; ② dense related-party funding arrangements: period-end deposit balance at Norinco Group Finance Company of RMB 19.184 billion (about 48% of cash on hand), cumulative group entrusted loans of RMB 1.55 billion (LPR-81bp), and termination of the RMB 3 billion related-party capital increase in Changan Technology in favor of market-based financing; ③ in Aug–Sep 2025, directors, supervisors and senior executives of the company and group collectively bought only 473,600 shares (0.0048% of total share capital) — more symbolic than substantive.
| Segment | Revenue/Scale | Earnings Contribution | YoY | Business Logic in One Sentence |
|---|---|---|---|---|
| Self-owned vehicles (consolidated, incl. Deepal 51%) | Consolidated revenue RMB 164.0 billion (2025) | The only consolidated profit source; gross margin 15.54% | Revenue +2.67% | Multi-brand matrix with scale manufacturing, trading volume for share in the price war |
| Of which: NEVs (consolidated basis) | Revenue RMB 80.276 billion, 48.9% of total (2025) | Deepal net loss RMB -899 million (narrowing); 2026H1 ex-non-recurring loss per vehicle only RMB 224 | Volume +51.1% (1.11 million units, 2025) | Ramp-up phase; losses narrowing but not yet breakeven |
| Of which: Overseas business | Revenue RMB 21.942 billion, 33.43% of total (2026H1) | Gross margin 20.13%, highest in the group | +78.77% (2026H1) | High-margin export engine; localized capacity ramping |
| JV — Changan Ford (equity method) | 2025 net profit RMB 952 million (not consolidated) | Equity income +RMB 465 million (2025) → only about RMB 131 million in 2026H1 | Continuous decline | ICE base shrinking; profit contribution heading toward zero |
| JV — Changan Mazda (equity method) | Not consolidated | RMB -96 million (2025), consecutive losses | Transition not yet profitable | Early stage of NEV transition with EZ-6/EZ-60 |
| Associate — Avatr (~40% stake) | Not consolidated; 2025 sales 120,000+ | Equity loss RMB -1.212 billion (2025) → RMB -649 million in 2026H1 | H1 deliveries -51% | High-end brand deeply tied to Huawei; HK IPO in progress |
Identifying the main profit driver: On a consolidated basis, self-owned vehicles are the only profit source, but structurally the "profit increment" comes from three places — overseas (gross margin 20.13% vs. 11.67% domestic, an 8.5pp gap — a price-realization gap of less than half the domestic margin, rooted in lower overseas competition intensity and higher channel premiums), Deepal loss narrowing (-1.572 → -0.899 billion), and JV stabilization (not yet happening). Drags are Avatr's equity losses (annualized about -RMB 1.2 billion) and diminishing marginal absorption by minority shareholders (minority interests fell from RMB 4.649 billion to 3.661 billion; at the current burn rate they will be exhausted in about 3 years, at which point Deepal's losses will flow back to the parent in full). From 2026, production/sales reports no longer break out monthly sales by brand (Nevo/Deepal/Avatr) — the decline in disclosure granularity itself is noteworthy.
Accounting red flags: ① R&D capitalization ratio rising consecutively 33.61%→35.96%→43.08%, with 2025 capitalized amount up +48.29% to RMB 5.418 billion; the annual report marked the reason for the large change as "not applicable" (severity: medium-high) — deferring expenses flatters current profit and directly inflates the quality of 2025's "+8.03% improvement" in ex-non-recurring earnings; ② high reliance of profit on one-off gains (severity: high): non-recurring gains of 7.546/4.734/1.280/0.567 billion for 2023–2026H1, with a different item rotating in each year; ③ inventory write-down provisions coexisting with high inventory (medium): RMB 463 million provided in 2026H1 (half-year provision already 2.3x the full-year 2025 amount of RMB 201 million); inventory of RMB 23.1 billion, inventory volume +56.32%; ④ accounts receivable surged +179.61% in Q1 before falling back in H1, attributed by the company to "increased support for dealers" (medium) — channel-stuffing-style funding support may borrow against future collections and real demand.
Cross-period consistency: The OCF trajectory (19.86→4.85→1.836 (estimated)→-11.41 billion) is directionally consistent with management's yearly explanations (new supplier payment-term policy → payment terms + export tariffs → reduced collections from maturing sales); the annual rotation of non-recurring items and the jump in R&D capitalization ratio — the company has not explained either; the divergence between expanding minority-shareholder losses and Deepal's sales growth was questioned by investors on the investor interaction platform; the company attributed it to "industry-wide factors such as FX and raw materials" — a weak explanation.
Current market data (close of 2026-10-26): Share price RMB 7.18, total share capital 9.913 billion shares, total market cap about RMB 71.175 billion (A-share price × total shares; Changan B trades at a ~62% discount, contributing less than 10% to market cap). PB of 0.94x — 5th percentile over 5 years, 8th percentile over 3 years, about 3% above the 5-year low; PE(TTM) 27.36x (83rd percentile — mechanically distorted by the collapsed earnings base, percentile is reference only, not a cheap/expensive signal); PE (static FY2025) 17.47x (50th percentile); PS(TTM) 0.45x; dividend yield 2.31%. Liquidity normal (average daily turnover about 0.6–0.8% of market cap); no liquidity risk warning needed.
| Peer | PE(TTM) | PB | 2026H1 Revenue Growth | 2026H1 Attributable Profit Growth | ROE (FY2025) | Key Difference vs. Changan |
|---|---|---|---|---|---|---|
| Changan Automobile | 27.4 | 0.94 | -9.7% | -64.3% | 5.3% | — |
| BYD | 25.5 | 3.13 | -7.1% | -20.5% | 15.1% | Vertical integration + overwhelming scale; not a peer |
| Geely Auto | 8.0 | 1.41 | +14.7% | -1.8% | 18.8% | Multi-brand with strength in both volume and profit; gap is per-model profitability |
| Great Wall Motor | 20.3 | 1.40 | +10.6% | -61.1% | 11.8% | Most comparable in exports + product mix; H1 profit similarly collapsed |
| Seres | 57.2 | 1.98 | -7.9% | Swung to loss | 22.4% | Huawei-affiliated high margins; H1 swing to loss confirms industry-wide issue |
| SAIC Motor | 13.5 | 0.42 | +0.2% | -14.4% | 3.4% | Deep JV dependence distress discount; bear-case reference |
Market-implied expectations: The current price implies operating value of about RMB 33 billion; backing out at a 10–12% cost of equity implies normalized attributable profit of about RMB 3.3–4.0 billion — between reported reality (2026H1 annualized about RMB 1.6–2.0 billion) and sell-side consensus 2027E (RMB 5.95 billion), and closer to this report's own 2026E (RMB 1.8–2.6 billion). In one sentence: the current price requires Changan to repair per-vehicle net profit from the reported RMB 730 (2026H1) to about RMB 1,700–2,000 (RMB 3.3–4.0 billion / ~2.3 million units), while management's "excluding FX" metric shows core operations already near RMB 2,300 — the repair narrative is not fantasy, but the market is only willing to pay for "halfway repaired."
Three-tier value (EPV): Asset value about RMB 7.06/share (floor, independent reference); zero-growth EPV about RMB 7.22/share (normalized FCFE of about RMB 3.0 billion/year: 2023–2025 ex-non-recurring average of RMB 3.055 billion, adjusted for JV decline -0.38 billion, Avatr loss narrowing +0.58 billion, Deepal to breakeven +0.45 billion, overseas increment +0.3 billion, adding back depreciation of RMB 6.29 billion, deducting maintenance capex of about RMB 5.0 billion and working capital increment of about RMB 1.0 billion, divided by a 9% cost of equity, plus net cash of RMB 38.57 billion); the current price of RMB 7.18 is almost entirely supported by "zero-growth status quo + net cash," with growth option value of about 0–2% of the price (backfilled by the system from actual EPV inputs; under a conservative cash-conversion approach the option premium cap is about 22%). Key caveat on the normalized approach: sensitivity to maintenance capex and working capital assumptions is about ±RMB 1.7/share.
Three scenarios and odds (12 months; fair-value ranges cross-anchored on PB/normalized PE):
| Scenario | Probability | Fair Range | vs. Current Price | Key Drivers |
|---|---|---|---|---|
| Bear | 30% | RMB 5.3–6.2 | -26.2% ~ -13.6% | 2026 ex-non-recurring turning negative + price war persisting into 2027, export tax rebate/tariff shocks falsifying the repair; PB toward 0.70–0.81x (referencing its own 10-year low and a SAIC-style distress discount) |
| Base | 50% | RMB 6.8–7.6 | -5.3% ~ +5.8% | Overseas profit release (2027E overseas revenue RMB 48–55 billion, net margin 5–6%, with an unquantified ~RMB 1 billion erosion from export tax rebate cuts as a downside sensitivity) + Deepal turning profitable + Ford stabilization; per-vehicle attributable profit repaired to RMB 1,900–2,400 |
| Bull | 20% | RMB 9.3–10.3 | +29.5% ~ +43.5% | Platformized intelligent-driving cost reduction per vehicle + overseas net margin above 6% + Avatr's 2027Q2 HK IPO triggering revaluation of long-term equity investments + Deepal profit beat (2027E attributable profit RMB 6.5–7.5 billion × 13.5–14x) |
Probability-weighted expectation about RMB 7.29 (+1.5%); the current price sits within the base-case band slightly below the midpoint — odds are symmetric-to-slightly-positive but without cushion. External anchor comparison: the most pessimistic on-record sell-side target of RMB 4.5 (Investing.com aggregate low; 3 of 9 analysts at sell) is about RMB 1 below this report's bear-case floor, corresponding to the extreme case of "2027 repair fully falsified + loss-making automaker framework" (PB about 0.59x); this report did not adopt it as the lower bound because the in-house 2026E attributable profit of RMB 1.8–2.6 billion has not fallen into a full loss, and net cash at 54% of market cap provides a liquidation-level buffer. The most optimistic anchor is the Moomoo aggregate average of 30 analysts at RMB 11.36 (0 sells; the A-share sell-side ecosystem where "buy" is the default carries systematic optimism bias) — above this report's bull-case ceiling, with the difference mainly in its implied 2027E earnings of ~RMB 6 billion+ and higher confidence in the repair. The base-case exit multiple (13–14x normalized PE / PB 0.9–1.0x) is anchored to Great Wall/SAIC's static 12–12.4x tier plus a premium for Changan's net cash and overseas structure, not to Changan's own current multiples.
In-house earnings forecast (reconciliation anchor): FY2026E revenue RMB 151.1–156.1 billion (-5% ~ -8%), attributable profit RMB 1.8–2.6 billion (ex-non-recurring RMB 0.4–1.0 billion); FY2027E revenue RMB 159.0–172.0 billion (+4% ~ +12%), attributable profit RMB 4.2–5.5 billion (ex-non-recurring RMB 3.2–4.5 billion). Drivers: volume ~2.15–2.22 million in 2026 → ~2.35–2.45 million in 2027; overseas revenue RMB 48–55 billion in 2027, net margin 5–6%; Deepal turning profitable contributing +RMB 0.4–0.5 billion; Avatr equity losses narrowing to RMB -0.6–0.8 billion; gross margin 14.3–15.0% → 15.0–15.5%. No quantitative guidance from management; this forecast is 35–55% below sell-side consensus (FY2026E RMB 3.965 billion), with divergence on FX, domestic demand, and the H2 delivery threshold.
Conclusion: valuation is fair; target price RMB 6.8–7.6 (base-case fair value), safety margin about -5% (base floor RMB 6.8 vs. current price RMB 7.18). Separating quality from price: the quality floor is solid (PB at the 5-year 5th percentile + net cash at 54% of market cap + 40% payout ratio + buybacks + overseas revenue at one-third of total with 20% gross margin), but earnings momentum is still bottoming (ROE 5.3%, ex-non-recurring profit near zero); the price is neither excessively beaten down nor bubbly — trading below book is not a reason to buy; ROE recovery is.
Industry Size: According to CAAM data (as cited in the company's periodic reports and media coverage), China's auto production/sales in January–September 2026 were 23.246/23.271 million units, slightly down YoY; H1 industry sales were 15.017 million units (-4.1%); September passenger vehicle sales fell -9.5% YoY—domestic demand slowed under the phase-out of purchase tax subsidies and a wait-and-see sentiment, and the industry has entered a zero-sum stock game (company IR terminology: "stock-market game, margins at historical lows"). New energy is the only structural source of growth: industry NEV sales grew +11.1% in the first three quarters (Xinhua citing CAAM), and Changan's own September NEV share reached 55.6%. Authoritative figures for full-year 2025 industry volume and 3–5-year CAGR were not obtained in this report (the industry research seat failed to produce them, honestly noted); a verifiable anchor: the common estimate of ~34 million units for 2025 China auto sales was not independently verified in this report and is not cited as a headline figure.
Value Chain and Value Distribution: OEMs sit at the relatively weaker end of the value chain in bargaining power—upstream battery materials (lithium carbonate prices back at high levels in 2026, copper prices persistently elevated) and automotive-grade memory chips (supply-demand imbalance, soaring prices, as explicitly stated in the company's interim report) squeeze the cost side, while downstream consumers are highly sensitive to end prices amid the price war; the intelligent-driving segment (Huawei Qiankun ADS/HarmonyOS cockpit, the Yinwang model) has captured product definition rights and corresponding profit shares in the premium segment. OEMs "trade binding for premium" (Avatr's full lineup with Huawei Qiankun ADS 5) but must pay for the partnership (Avatr previously invested approximately RMB 11.5 billion in Yinwang equity to bind with Huawei, per Huxiu's July 2026 retrospective). Where gross margin sits in the chain: at the two ends—scale + vertical integration players (BYD) and brand-premium players (Huawei-affiliated)—while multi-brand independent OEMs in the middle (Changan/Great Wall/SAIC) are squeezed from both sides—Changan's 2026H1 domestic gross margin of just 11.67% is a manifestation of this structure.
Supply-Demand and Competitive Landscape: The dominant theme of this round of competition is the price war ongoing since 2023 compounded by demand fade in 2026: BYD 2026H1 revenue -7.1%, net profit attributable -20.5%; Great Wall revenue +10.6% but net profit -61.1%; Seres turned to a loss (-RMB 1.717 billion); Geely is the only top player stable in both volume and profit (revenue +14.7%, net profit -1.8%); SAIC net profit -14.4%. Five of the top six saw double-digit declines in 2026H1 profit, indicating a substantial industry-driven component in Changan's -64.32%—but with the industry broadly flat while Changan's sales fell -18.07%, the 18-percentage-point underperformance reflects individual share loss and cannot be entirely attributed to the industry. Concentration (CR3/CR5) figures were not obtained in this report (honestly noted); observable structural facts: after NEV penetration passed 50%, competition shifted from "ICE-to-EV substitution" to "EV-vs-EV involution," and players with large ICE bases (Changan Nevo/Ford/Mazda) are being forced to shrink fastest. Exports have become a shared second growth curve, but the NEV export tax rebate cut from 13% to 9% effective 2027-04-01 (Ministry of Finance announcement, 2026-10-12) plus the EU's countervailing duties on Chinese BEVs (20.7% applicable to non-sampled cooperating companies) are raising the cost of going global and accelerating local plant construction (Changan in Thailand/Brazil/Europe, BYD in Brazil/Hungary on the same path).
Cycles and Regulation: The policy calendar dictates demand rhythm—① NEV purchase tax halved (5%) in 2026–2027, restored in full in 2028; Q4 2027 will form a second rush-to-buy window; ② trade-in policy extended to January 2027, making Q4 2026 the "last train" window; ③ export tax rebate cut (effective 2027-04-01) creates an export-front-running pulse in Q4 2026–Q1 2027, followed by giveback in H2 2027; ④ EU countervailing duties and various countries' localization regulations continue to raise compliance barriers. Assessment of the industry's stage: the price war has entered the later phase of shakeout characterized by "margins at historical lows + high inventories"; anti-involution policy direction (repeated statements by regulators) and new payment-term rules (60 days) are administratively compressing competitive intensity, but on the demand side (purchase tax restored in full in 2028) no right-side signal has yet emerged.
Company Positioning: Within the independent-brand camp, Changan is in a "challenger" position with a declining share trend—January–September 2026 sales -18.07% vs. a broadly flat industry (wholesale basis; domestic decline even deeper against the backdrop of high export growth). Sources of moat: central SOE background (the Ordnance system, financing and resource backing—the major shareholder subscribed to this private placement at a 31% premium, plus a group low-interest entrusted loan of RMB 1.55 billion) + deep Huawei binding (Avatr/Deepal S series equipped with Qiankun intelligent driving) + first-mover overseas channels (17 KD projects in 8 countries, production in Thailand/Brazil); weaknesses: per-vehicle profitability (RMB 224 non-GAAP per unit) significantly weaker than Geely and BYD, with no advantage in either brand premium or cost control. Discrepancy between third-party and company-stated figures: the company claims 2025 sales of 2.913 million units, "ranking fourth in the industry" (annual report basis), while third-party data on 2026 share rankings were not obtained in this report—based on January–September 2026 dynamics, the gap between Changan and the leaders (BYD/Geely/Chery) is widening, not narrowing.
| Metric | 2023 | 2024 | 2025 | 2026H1 |
|---|---|---|---|---|
| Total sales (10k units) | 255.3 | 268.4 | 291.3 | 111.9 |
| ASP (RMB 10k/unit, consolidated revenue/total sales) | 5.93 | 5.95 | 5.63 | 5.87 |
| Net profit attributable per unit (RMB) | 4,437 | 2,728 | 1,399 | 730 |
| Non-GAAP net profit per unit (RMB) | 1,481 | 964 | 959 | 224 |
| Capacity utilization (%) | 87.31 | 84 | 88.2 | Not disclosed |
| Export/overseas share of sales (%) | 14.0 | 20.0 | 21.9 | 40.7 |
| NEV share of sales (%) | — | — | 38.1 | 40.8 (41.9% for Jan–Sep) |
Interpretation: Volume peaked in 2025 and stalled in 2026 (-18.07% for Jan–Sep); price, after a sustained slide, was stabilized in 2026H1 by export and NEV mix (ASP RMB 58,700); profit is the steepest collapse—per-unit attributable profit shrank 84% over three and a half years (RMB 4,437→730), and per-unit non-GAAP profit is down to just RMB 224, at the level of "earning a bottle of motor oil per car sold." The three-stage rocket for a turnaround: overseas (gross margin 20.13% + volume ramp) > NEV loss reduction (Deepal at -RMB 899 million with monthly sales firmly above 28,000 units) > new-model cycle diluting fixed costs. Model cycle: over 10 all-new and facelift models to be launched in 2026—Qiyuan Q06 (launched in September, 35,000 orders in 24 hours, priced RMB 139,900–169,900, full lineup with Tianshen Pilot intelligent driving), Avatr 9 series (Huawei co-created flagship, Q4 launch), Avatr 07L (launched in August, full lineup with Qiankun ADS 5), new Deepal S05, fourth-generation CS75 PLUS—Q4 through H1 2027 is a dense new-model realization window, and the timing of per-unit profit recovery hinges on it. Capacity: designed capacity of 2.25 million units (NEV capacity 1.73 million); if 2026 sales land within this report's forecast of 2.15–2.22 million units, utilization will fall to around 72–75%, and deteriorating fixed-cost absorption is the primary mechanical channel for the earnings downgrade; overseas capacity in Thailand (100k→200k units) and Brazil represents incremental volume.
Rating: Neutral (confidence 0.55, 6–12 months). Changan's asset base (net cash of RMB 38.6 billion, PB 0.94, zero share pledges and no unlock overhang, major shareholder's premium private placement + buyback-and-cancellation + 40% payout ratio) provides downside cushioning, but its earnings momentum (per-unit non-GAAP profit of RMB 224, ROE 5.3%, cash flow turning negative) means upside lacks an engine—at the current price of RMB 7.18, effectively "zero-growth pricing," with expected return of roughly +1.5%, not a reason to act. Strategy: neither chase longs nor short at the current price; conditional watch triggers—once two to three of the validation signals (Q3 non-GAAP profit stabilizing sequentially, monthly sales decline narrowing to single digits in October–December, overseas monthly sales holding above 90,000 units, private placement launch) materialize, odds turn favorable, at which point re-rate along the base→bull scenario path; if the stock first falls toward the RMB 6.8 floor (base-case lower bound) without deterioration in validation signals, the risk-reward ratio would improve.
Key Risks and Falsification Conditions: ① Q4 sales decline fails to narrow + full-year non-GAAP profit turns negative (C1 deteriorates); ② overseas monthly sales below 80,000 units for two consecutive months or overseas gross margin below 18% (C3 invalidated); ③ private placement approval expires in August 2027 without implementation (C5 buffer falls through); ④ stock price breaks below RMB 5.3 (valuation framework reassessment); ⑤ concentrated Q4 inventory impairment swallows full-year profit (annual risk on an inventory base of RMB 23.1 billion). Catalyst Calendar: October 31 Q3 report → Q4 Avatr 9 series launch / Qiyuan Q06 ramp → January 2027 trade-in program closing → early 2027 private placement issuance window → Q2 2027 targeted date for Avatr's Hong Kong IPO → April 2027 export tax rebate cut takes effect (preceded by an export-front-running pulse).
Data and Basis Notes: Financial data in this report are drawn from the company's FY2023–FY2025 annual reports, Q1 2026 report, H1 2026 report, and Juchao ad hoc announcements (as of 2026-10-27); the Q3 2026 report has not yet been disclosed. The valuation anchor is the closing price of RMB 7.18 on 2026-10-26 (A-share, RMB). Industry aggregate data are from CAAM (as cited in company reports and media coverage); the independent industry research seat failed to produce output this time, and figures such as industry concentration and full-year 2025 totals are marked as "not obtained." This report was generated by Loyan AI and is for research reference only; it does not constitute investment advice.